The Landscape of SERCA2 in Cardiovascular Diseases: Expression Regulation, Therapeutic Applications, and Emerging Roles
Biomolecules · 04.02.2026 · 16 (2) · 247
DOI: 10.3390/biom16020247 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.02.2026. Verfasst von Jianmin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Zunyi Medical University, Zunyi 563000, China. Hauptthemen laut MEDLINE: Sarcoplasmic Reticulum Calcium-Transporting ATPases, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Driven by rapid socioeconomic progress and changing lifestyles, the global burden of cardiovascular diseases (CVDs) continues to escalate, with surging morbidity and mortality rates imposing a severe threat to public health. Clinical treatments are focused on the alleviation of treatments, highlighting the need for a deeper understanding of CVDs pathogenesis and the development of targeted therapies. Recent studies have identified imbalances in intracellular Ca2+ homeostasis as a key pathological mechanism in the progression of CVDs. Notably, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2 (SERCA2), a membrane protein encoded by the ATP2A2 gene and ranging from 97 to 115 kDa in molecular weight, plays a pivotal role in regulating intracellular Ca2+ levels. Extensive evidence links abnormal SERCA2 function to various CVDs, including heart failure, cardiac hypertrophy, atherosclerosis, and diabetic cardiomyopathy. This review systematically explores the regulatory mechanisms of SERCA2 expression and its functional regulation—including transcriptional regulation, post-translational modifications, and protein–protein interactions—and further investigates its pathological roles in cardiovascular diseases as well as its potential as a therapeutic target. By synthesizing current knowledge, this article aims to provide new insights for future basic research and establish a theoretical foundation for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Zunyi Medical University, Zunyi 563000, China.
- Key Laboratory for Cancer Prevention and Treatment of Guizhou Province, Zunyi 563000, China.
- Key Laboratory of Gene Detection and Treatment of Guizhou Province, Zunyi 563000, China.
ORCID-Profile: Juanjuan Zhao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wu, J., Liao, M., Dai, T., Liu, G., Zhang, J., Zhu, Y., Xu, L., & Zhao, J. (2026). The Landscape of SERCA2 in Cardiovascular Diseases: Expression Regulation, Therapeutic Applications, and Emerging Roles. Biomolecules, 16(2), 247. https://doi.org/10.3390/biom16020247
Vancouver
Wu J, Liao M, Dai T, Liu G, Zhang J, Zhu Y, et al. The Landscape of SERCA2 in Cardiovascular Diseases: Expression Regulation, Therapeutic Applications, and Emerging Roles. Biomolecules. 2026;16(2):247. doi:10.3390/biom16020247
BibTeX
@article{Wu2026,
author = {Wu, Jianmin and Liao, Mengting and Dai, Tengkun and Liu, Guiyan and Zhang, Jiayi and Zhu, Yiling and Xu, Lin and Zhao, Juanjuan},
title = {The Landscape of SERCA2 in Cardiovascular Diseases: Expression Regulation, Therapeutic Applications, and Emerging Roles},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {2},
pages = {247},
doi = {10.3390/biom16020247}
}
EUVIMED